AR015425A1 - Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion - Google Patents
Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacionInfo
- Publication number
- AR015425A1 AR015425A1 ARP980104362A ARP980104362A AR015425A1 AR 015425 A1 AR015425 A1 AR 015425A1 AR P980104362 A ARP980104362 A AR P980104362A AR P980104362 A ARP980104362 A AR P980104362A AR 015425 A1 AR015425 A1 AR 015425A1
- Authority
- AR
- Argentina
- Prior art keywords
- cr8r8
- optionally substituted
- integer
- alkyl
- value
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos de benzotiazol utiles para el tratamiento de estados de enfermedad que ocurren por mediacion de la quimioquina, Interleuquina-8 (IL-8) de laformula (I)en la que: Res -NH -C(X)-NH-(CR13R14)v - Z; Z es W, hereroarilo opcionalmente sustituido,cicloalquilo de C5-8 opcionalmente sustituido,alquilo C1-10opcionalmente sustituido,alquenilo C2-10 opcionalmente sustituido, o un alquinilo C2-10 opcionalmente sustituido, X es =O, o =S; A es CR20R21; R1 se seleccionaindependientemente entre H; halogeno; nitro, ciano; alquilo de C1-10 halosustituido;alquilo de C1-10;alquenilo de C2-10;alcoxi de C1-10; alcoxi de C1-10halosustituido; azida; (CR8R8)qS(O)tR4, hidroxi; hidroxialquilo de C1-4; arilo; arilalquilo de C1-4; ariloxi; arilalquiloxi de C1-4; heteroarilo, heteroarilalquilo; heterocíclico; heterociclicoalquilo de C1-4; heteroarilalquiloxi de C1-4; arilalquenilo de C2-10; heteroarilalquenilo de C2-10; heterociclicoalqueniloC2-10; (CR8R8)qNR4R5; alquenilo de C2-10C(O)NR4R5; (CR8R8)qC(O)NR4R5; (CR8R8)qC(O)NR4R10; S(O)3H; S(O)3R8; (CR8R8)qC(O)R11; alquenilo de C2-10C(O)R11;alquenilo de C2-10C(O)OR11; (CR8R8)qC(O)OR11; (CR8R8)qC(O)OR12; (CR8R8)qOC(O)R11; (CR8R8)qNR4C(O)R11; (CR8R8)qC(NR4)NR4R5; (CR8R8)qNR4C(NR5)R11;(CR8R8)qNHS(O)2R17;(CR8R8)qS-(O)2-NR4R5; o dos restos R1 juntos pueden formar O-(CH2)sO o un anillo saturado o insaturado de 5 a 6 miembros, y en el que losanillos arilo, heteroarilo y heterocíclico pueden estar opcionalmente sustituidos; n es un numero entero que tiene un valor de 1 a 3; m es un numero entero quetiene un valor de 1 o 3; q es O o un numero entero que tiene un valor de 1 a 10; t es 0, o un numero entero que tiene un valor de 1 o 2; s es un numero enteroque tiene un valor de 1 a 3; v es 0 o un numero entero que tiene un valor de 1 a 4; R4 y R5 son independientemente hidrogeno, alquilo de C1-4 opcionalmentesustituido, arilo opcionalmente sustituido, arilalquilo de C1-4 opcionalmente sustituido, heteroarilo opcionalmente sustituido, heteroarilalquilo de C1-4opcionalmente sustituido, heterocíclico, heterocíclico alquilo de C1-4, o R4 y R5 junto con el nitrogeno al que están unidos forman un anillo de 5 a 7 miembros
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5799897P | 1997-09-05 | 1997-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015425A1 true AR015425A1 (es) | 2001-05-02 |
Family
ID=22014023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104362A AR015425A1 (es) | 1997-09-05 | 1998-09-01 | Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion |
Country Status (17)
Country | Link |
---|---|
US (1) | US6297265B2 (es) |
EP (1) | EP1003509A4 (es) |
JP (1) | JP2001514225A (es) |
KR (1) | KR20010023672A (es) |
CN (1) | CN1278726A (es) |
AR (1) | AR015425A1 (es) |
AU (1) | AU732728B2 (es) |
BR (1) | BR9812176A (es) |
CA (1) | CA2302450A1 (es) |
CO (1) | CO4970747A1 (es) |
HU (1) | HUP0004646A3 (es) |
IL (1) | IL134855A0 (es) |
NO (1) | NO20001100D0 (es) |
PL (1) | PL339134A1 (es) |
TR (1) | TR200000611T2 (es) |
WO (1) | WO1999011264A1 (es) |
ZA (1) | ZA988100B (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
PE20011124A1 (es) | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
DE10038709A1 (de) * | 2000-08-09 | 2002-02-28 | Aventis Pharma Gmbh | Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen |
WO2002043758A2 (en) * | 2000-12-01 | 2002-06-06 | Schering Corporation | Uses of mammalian genes and related reagents |
US20030204085A1 (en) * | 2001-02-02 | 2003-10-30 | Taveras Arthur G. | 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
US7132445B2 (en) * | 2001-04-16 | 2006-11-07 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
CN1599734A (zh) * | 2001-10-12 | 2005-03-23 | 先灵公司 | 作为cxc趋化因子受体拮抗剂的3,4-二取代的马来酰亚胺化合物 |
US6878709B2 (en) * | 2002-01-04 | 2005-04-12 | Schering Corporation | 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
CN100444839C (zh) * | 2002-03-18 | 2008-12-24 | 先灵公司 | 式(i)化合物在制备治疗化学激活物中介的疾病的药物中的应用 |
US20040186142A1 (en) * | 2002-10-09 | 2004-09-23 | Schering Corporation Pharmacopeia, Inc. | Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands |
TW200418812A (en) * | 2002-10-29 | 2004-10-01 | Smithkline Beecham Corp | IL-8 receptor antagonists |
DE10345403A1 (de) * | 2003-09-30 | 2005-04-28 | Infineon Technologies Ag | Material und Zellenaufbau für Speicheranwendungen |
EP1694659B8 (en) * | 2003-12-19 | 2008-10-08 | Schering Corporation | Thiadiazoles as cxc- and cc- chemokine receptor ligands |
TW200530231A (en) * | 2003-12-22 | 2005-09-16 | Schering Corp | Isothiazole dioxides as CXC-and CC-chemokine receptor ligands |
CN1984899B (zh) | 2004-05-12 | 2011-07-27 | 先灵公司 | Cxcr1和cxcr2趋化因子拮抗剂 |
WO2006043950A1 (en) * | 2004-10-20 | 2006-04-27 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
JP2009500328A (ja) * | 2005-06-29 | 2009-01-08 | シェーリング コーポレイション | Cxc−ケモカインレセプターリガンドとしての5,6−ジ−置換オキサジアゾロピラジンおよびチアジアゾロピラジン |
EP1912971A2 (en) * | 2005-06-29 | 2008-04-23 | Shering Corporation | Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
EA014958B1 (ru) * | 2006-04-21 | 2011-04-29 | Смитклайн Бичам Корпорейшн | Антагонисты рецептора il-8 |
EP2010180A4 (en) * | 2006-04-21 | 2010-10-13 | Glaxosmithkline Llc | IL-8 RECEPTOR ANTAGONISTS |
PE20080943A1 (es) * | 2006-06-23 | 2008-09-27 | Smithkline Beecham Corp | Sal toluenosulfonato de 4-{[6-cloro-3-({[(2-cloro-3-fluorofenil)amino]carbonil}amino)-2-hidroxifenil]sulfonil}-1-piperazinacarboxilato de 1,1-dimetiletilo como antagonista del receptor de il-8 |
TW200813033A (en) * | 2006-07-07 | 2008-03-16 | Schering Corp | 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor ligands |
WO2018007323A1 (en) | 2016-07-04 | 2018-01-11 | Bayer Cropscience Aktiengesellschaft | Benzosultams and analogues and their use as fungicides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4794114A (en) * | 1986-08-19 | 1988-12-27 | Smithkline Beckman Corporation | Inhibition of interleukin-1 production by monocytes and/or macrophages |
CA2188772A1 (en) | 1994-06-08 | 1995-12-14 | Balreddy Kamireddy | Cyclic sulfonamide herbicides |
JP3720395B2 (ja) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | 新規ヘテロ環誘導体、その製造方法およびその医薬用途 |
TR199800655T2 (xx) * | 1995-10-05 | 1999-09-21 | Kyoto Pharmaceutical Industries, Ltd. | Yeni heterosiklik t�revler ve bunlar�n farmas�tik kullan�mlar�. |
AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
US5929250A (en) * | 1997-01-23 | 1999-07-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
-
1998
- 1998-09-01 AR ARP980104362A patent/AR015425A1/es not_active Application Discontinuation
- 1998-09-04 US US09/508,039 patent/US6297265B2/en not_active Expired - Fee Related
- 1998-09-04 IL IL13485598A patent/IL134855A0/xx unknown
- 1998-09-04 CO CO98050791A patent/CO4970747A1/es unknown
- 1998-09-04 CA CA002302450A patent/CA2302450A1/en not_active Abandoned
- 1998-09-04 JP JP2000508367A patent/JP2001514225A/ja active Pending
- 1998-09-04 HU HU0004646A patent/HUP0004646A3/hu unknown
- 1998-09-04 WO PCT/US1998/018569 patent/WO1999011264A1/en not_active Application Discontinuation
- 1998-09-04 TR TR2000/00611T patent/TR200000611T2/xx unknown
- 1998-09-04 PL PL98339134A patent/PL339134A1/xx unknown
- 1998-09-04 EP EP98949318A patent/EP1003509A4/en not_active Withdrawn
- 1998-09-04 CN CN98810909A patent/CN1278726A/zh active Pending
- 1998-09-04 BR BR9812176-6A patent/BR9812176A/pt not_active Application Discontinuation
- 1998-09-04 KR KR1020007002325A patent/KR20010023672A/ko not_active Application Discontinuation
- 1998-09-04 AU AU95663/98A patent/AU732728B2/en not_active Ceased
- 1998-09-04 ZA ZA988100A patent/ZA988100B/xx unknown
-
2000
- 2000-03-03 NO NO20001100A patent/NO20001100D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO4970747A1 (es) | 2000-11-07 |
WO1999011264A1 (en) | 1999-03-11 |
ZA988100B (en) | 1999-03-05 |
AU9566398A (en) | 1999-03-22 |
IL134855A0 (en) | 2001-05-20 |
JP2001514225A (ja) | 2001-09-11 |
HUP0004646A3 (en) | 2002-12-28 |
CA2302450A1 (en) | 1999-03-11 |
EP1003509A4 (en) | 2002-11-20 |
KR20010023672A (ko) | 2001-03-26 |
NO20001100L (no) | 2000-03-03 |
AU732728B2 (en) | 2001-04-26 |
US20010018447A1 (en) | 2001-08-30 |
US6297265B2 (en) | 2001-10-02 |
CN1278726A (zh) | 2001-01-03 |
PL339134A1 (en) | 2000-12-04 |
BR9812176A (pt) | 2001-12-18 |
NO20001100D0 (no) | 2000-03-03 |
HUP0004646A2 (hu) | 2001-09-28 |
TR200000611T2 (tr) | 2000-08-21 |
EP1003509A1 (en) | 2000-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015425A1 (es) | Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion | |
ATE140218T1 (de) | Phenylimidazolidine, verfahren zu deren herstellung, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen | |
AR015157A1 (es) | DERIVADOS DEL ÁCIDO 5-ALQUIL-2-ARILAMINOFENILÁCETICO, COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE, SU USO EN LA MANUFACTURA DE UN MEDICAMENTO Y MÉTODO DE PREPARACIoN DEL MISMO | |
DK142084A (da) | N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf | |
ATE1947T1 (de) | 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung. | |
CO5031286A1 (es) | Compuestos de ciano guanadina como antagonistas de los receptores de il-8 y metodo de preparacion | |
AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
FI961914A (fi) | Lyhytvaikutteiset dihydropyridiinit | |
DE58904143D1 (de) | Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. | |
AR033803A1 (es) | Compuestos de dianilino escuarano, composiciones farmaceuticas que los comprenden, y el uso de los mismos en la fabricacion de medicamentos para tratar enfermedades mediadas por quimioquinas | |
ATE86602T1 (de) | Alpha,alpha disubstituierte n-cycloalkylalkylbenzylamine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und ihre zwischenprodukte bei der herstellung. | |
AR008331A1 (es) | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen | |
DE3883140D1 (de) | Imidazo(2,1-b)benzothiazole und ihre saeureadditionssalze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen. | |
AR015426A1 (es) | Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion | |
ES2177656T3 (es) | Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis. | |
DE59108744D1 (de) | 8-EN-19, 11 beta-ÜBERBRÜCKTE STEROIDE, DEREN HERSTELLUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE | |
ATE24509T1 (de) | Triazoloquinazolone und deren salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
FI873009A0 (fi) | Foerfarande foer framstaellning av (2-dimetylaminoetyl)-/2-/(2-tiometylfenyl)-(fenylmetyl)/amino-2-oxoetyl /karbamater eller -karbamider. | |
ATE11915T1 (de) | Benzothiazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung. | |
AR034557A1 (es) | Derivados de (2-azabiclo[2.2.1]hept-7-il)metanol como agonistas de receptores nicotinicos de acetilcolina | |
ATE31410T1 (de) | Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung. | |
ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE112275T1 (de) | Disubstituierte polymethylenimine, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
DE68906827D1 (de) | Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE55611T1 (de) | 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |